-
PUBLICATION
2023.05.31
SMC is proud to announce that Chugai Pharmaceutical Co., Ltd. (JPN) has published the results of their study using our pre-clinical services with the STAM™ mouse in Pharmacol Res Perspect.
-
PRODUCTS AND SERVICES
Introduction of Inflammatory Bowel Disease mouse model
2023.05.24
Today, we give you a brief introduction to the dextran sulfate sodium (DSS) -induced colitis model, which is a clinically representative mouse model that can be used to conduct drug efficacy studies targeting Inflammatory Bowel Disease.
-
PUBLICATION
2023.05.17
SMC is proud to announce that Agency for Science, Technology and Research (A*STAR) (SGP) has published the results of their study using our pre-clinical services with the STAM™ model in Int. J. Mol. Sci.
-
NEWS RELEASE
Announcement of webinar 【HOW NAFLD ACTIVITY SCORE IS SCORED IN NON-CLINICAL STUDIES】
2023.05.10
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place on May 18th (JST) from 9:30 AM.
-
PUBLICATION
The STAM™ mouse model: a clinically relevant, spontaneous HCC model
2023.04.26
We would like to introduce a study published by our client using our STAM™ mouse model (Dow, et al. Proc Natl Acad Sci U S A. 2018).
-
PRODUCTS AND SERVICES
Introduction of chronic kidney disease mice models
2023.04.19
I am writing you today to share some information on our Chronic kidney disease (CKD) models.
-
UPCOMING EVENTS
SMC attend Digital partnering events!
2023.04.12
We are pleased to announce that SMC Laboratories will be virtually attending the following digital events in May 2023.
-
PRODUCTS AND SERVICES
Introduction of NASH model with high clinical correlation
2023.03.29
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. Around the world, the prevalence of NAFLD has now increased to 30%, and it is expected to continue to increase [Younossi Z et al., Hepatology. 2023].
-
PUBLICATION
2023.03.22
SMC is proud to announce that Hyogo Medical University (JPN) has published a study featuring histopathological data evaluated by our scientists here at SMC.
-
PUBLICATION
Study published in Cell Metabolism on the efficacy of MGAT2 inhibitor in STAM™
2023.03.15
SMC is proud to announce that Bristol-Myers Squibb (NJ) has published the results of their study using our pre-clinical services with the STAM™ model in Cell Metabolism.
-
NEWS RELEASE
March 9th is World Kidney Day!
2023.03.08
Today, in celebration of World Kidney Day, we would like to share with you a little bit about the campaigns history, as well as what the purpose of it is. World Kidney Day aims to raise awareness of the important role that the kidney plays, as well as reduce kidney disease and other related health problems. The campaign is an initiative run by the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations – World Kidney Alliance (IFKF-WKA), where they host many different events around the world with the goal of increasing public understanding of how to prevent kidney disease, recognize its risk factors and live with it.
-
NEWS RELEASE
Introduction of Bile duct ligation (BDL)-induced primary biliary cirrhosis model
2023.03.02
Today, we would like to introduce our bile duct ligation (BDL)-induced primary biliary cirrhosis disease model.
